Palatin Technologies Inc (PTN): Total Assets
$8.52M
As of 2026-06-30
$4.72M
As of 2026-09-30
-22.0%
3-year compound annual growth
-33.9%
5-year compound annual growth
-2.4%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $8.52M | +160.9% | 2026-09-28, Balance as of period end |
| 2025-06-30 | $3.27M | -69.6% | 2026-09-28, Balance as of period end |
| 2024-06-30 | $10.74M | -40.1% | 2025-09-23, Balance as of period end |
| 2023-06-30 | $17.94M | -50.3% | 2024-09-30, Balance as of period end |
| 2022-06-30 | $36.07M | -46.4% | 2023-09-28, Balance as of period end |
| 2021-06-30 | $67.30M | -20.9% | 2022-09-22, Balance as of period end |
| 2020-06-30 | $85.05M | -18.8% | 2021-09-28, Balance as of period end |
| 2019-06-30 | $104.74M | +168.4% | 2020-09-25, Balance as of period end |
| 2018-06-30 | $39.02M | -31.3% | 2019-09-12, Balance as of period end |
| 2017-06-30 | $56.83M | +423.4% | 2018-09-13, Balance as of period end |
| 2016-06-30 | $10.86M | n/c | 2017-09-25, Balance as of period end |
| 2015-06-30 | $29.47M | +134.7% | 2016-09-19, Balance as of period end |
| 2014-06-30 | $12.56M | -49.9% | 2015-09-18, Balance as of period end |
| 2013-06-30 | $25.07M | +366.0% | 2014-09-12, Balance as of period end |
| 2012-06-30 | $5.38M | -74.6% | 2013-09-27, Balance as of period end |
| 2011-06-30 | $21.17M | n/a | 2012-09-10, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Palatin Technologies Inc (PTN) | 2026-06-30 | $8.52M | +160.9% |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 2025-12-31 | $277.17M | +70.2% |
| Evommune, Inc. (EVMN) | 2025-12-31 | $224.95M | +195.8% |
| CV Sciences, Inc. (CVSI) | 2025-12-31 | $6.96M | -12.2% |
| Pyxis Oncology, Inc. (PYXS) | 2025-12-31 | $91.52M | -41.8% |
| Emmaus Life Sciences, Inc. (EMMA) | 2025-12-31 | $21.44M | -9.2% |
| Arbutus Biopharma Corp (ABUS) | 2025-12-31 | $94.62M | -28.2% |
| Opus Genetics, Inc. (IRD) | 2025-12-31 | $50.24M | +36.3% |
| Prelude Therapeutics Inc (PRLD) | 2025-12-31 | $141.31M | -19.5% |
Compare PTN, TNXP, EVMN, CVSI side by side · Screen every company in Pharmaceutical Preparations ↗